When conventional pharmacotherapy falls short, brain stimulation methods are increasingly being utilized. Neuromodulation techniques: TMS, DBS, and ECT offer evidence-based options for treatment-resistant depression, obsessive-compulsive disorder, and bipolar disorder. Transcranial magnetic stimulation (TMS) provides non-invasive stimulation with minimal side effects, while deep brain stimulation (DBS) targets specific circuits via implanted electrodes. Electroconvulsive therapy (ECT), though often misunderstood, remains highly effective in severe cases, especially in acute suicidal ideation or catatonia. Each method demands precise clinical evaluation and ethical considerations, particularly regarding consent and potential cognitive effects. Advances in imaging and targeting technologies are enhancing safety and efficacy, marking neuromodulation as a critical frontier in modern psychiatry for those in need of advanced intervention strategies.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States